Skip to Main Content

Paper Details

PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors.
J Clin Invest
791
2014
- TIL populations, 4-1BB, CD137, CD223, CD279, CD8, CD8 TILs, CD8 lymphocytes, CD8 tumor, CD8PD, CD8PD-, CD8PD-1, CD8PD-1 populations, CD8PD-1- TIL populations, LAG-3, PD-1, T cell immunoglobulin and mucin domain 3, T cells, TCR, TCR chain, TCR clonotypes, TILs, TIM-3, clonally expanded tumor-reactive cells, human, lymphocyte-activation gene, lymphocyte-activation gene 3, malignancies, melanoma tumors, metastatic melanoma, mutated neoantigen-specific CD8 lymphocytes, patient, programmed cell death 1, reactive, tumor, tumor-infiltrating lymphocytes, tumor-reactive and mutation-specific CD8 lymphocytes, tumor-reactive population, tumors

Datasets

Release 1.2